Medical Device News Magazine

KA Imaging’s Reveal 35C Shown to Find More Pneumonia Cases than Traditional X-Ray

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Data drives decisions and with the latest trial data, we are positioned for growth,” says Amol Karnick, President and CEO of KA Imaging. In a paper presented earlier this year, the Reveal 35C technology was shown to detect 25% more pneumonia cases (including COVID-19) than traditional X-Ray1.

Reveal 35C is the world’s first single exposure portable dual-energy X-ray detector. Reveal is retrofittable and can be called a detector-side dual-energy upgrade: simply by replacing the detector, any existing X-ray system can be upgraded to dual-energy. With the same radiation dose as a chest X-ray, it creates 3 images without motion artifacts (standard digital X-ray, soft tissue and bone), giving the ability to see the lungs and soft tissue without having bones obstructing the view.

The paper presents the initial results of an ongoing clinical trial that is being carried out in Toronto (Canada). “Although Reveal has been available for sale in both the US and Canada for the past year, we have enrolled Reveal in a number of clinical trials to demonstrate the significant improvement in clinical outcomes compared to standard digital X-ray,” says Karnick.

According to the company, Reveal 35C enhances the use of dual energy, benefiting not only radiologists, but the entire service chain.

“It’s good for radiologists, who can access supplementary dual energy X-ray images for faster and easier reading,” explains Karnick. “It’s good for imaging technologists, who can offer patients more comfort by bringing the detector to the point of care and getting high-quality images even in challenging settings such as critical care units; it’s good for administrators, who can optimize the use of other equipment across multiple departments; and it is especially good for patients, who have more comfort and early access to treatment for diseases that could go unnoticed until they become more serious”, he concludes.


  1. Sanchez F, Kandel S, May M, Ronghe S, Rogalla P. Diagnostic value of dual-energy chest x-ray in immunocompromised patients to rule out pneumonia: initial results. European Congress of Radiology-ECR 2021, 2021.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”